SCHEMBL6950562

SCHEMBL6950562

CC(C)CCc1nc(N)nc2[nH]cnc12

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 7/20 0.42
CCNB1 P14635 7/20 0.42
CCNA2 P20248 7/20 0.42
CDK2 P24941 7/20 0.42
CCNA1 P78396 7/20 0.42
HRH4 Q9H3N8 6/20 0.36
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
HTT P42858 2/20 0.31
PDPK1 O15530 1/20 0.30
GDA Q9Y2T3 1/20 0.30
HRH2 P25021 1/20 0.30
HRH1 P35367 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12844134 0.79 HEXA (0.37) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL16146189 0.77 CYP1A2 (0.42) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL7527092 0.77 CDK1 (0.31) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL17485502 0.77 CDK1 (0.33) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL4455870 0.76 CDK2 (0.62) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL19839 0.76 CDK1 (0.36) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL17485430 0.75 KDM4A (0.43) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL6950876 0.75 MPO (0.56) CDK1CCNB1CCNA2CDK2CCNA1
Hydrochloric Acid SCHEMBL5731125 0.74 TLR7 (0.35)
SCHEMBL17483530 0.73 CDK1 (0.32) CDK1CCNB1CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1349857-A1 PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RESEARCH LIMITED (GB) 2003-10-08 EP disclosed
WO-2002055521-A1 PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RESEARCH LIMITED (GB) 2002-07-18 WO disclosed